Fundraising FoxDe Novo Ventures
Boston · 6 people tracked
Find your way into De Novo Ventures
Sign up to see every warm intro you have to De Novo Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the De Novo Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Team · 6 people
from public directories
What they invest in
from 7 of 9 portfolio companiesBiotech ×5Healthtech ×5Medical Devices ×2AI & Machine Learning ×1Consumer ×1FemTech ×1
HQs:United States×9
Investments · 9 tracked
founders shown can be your intro pathBy year:2024 · 12021 · 12019 · 12014 · 12013 · 12010 · 16 dated
Agile Therapeutics develops and markets contraceptive and women's health products using its proprietary Skinfusion® transdermal technology platform.
BiotechFemTechHealthtechPrinceton, US
Katie MacFarlane(Executive Officer)inScott M. Coiante(Executive Officer)Al Altomari(Executive Officer, Director)inElizabeth Garner(Executive Officer)in
BoardKaren Hong(Director)inAbhijeet Lele(Director)
Co-investorsAisling CapitalKaiser Permanente Ventures
Cyteir is a clinical-stage oncology company developing CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters.
BiotechHealthtechCambridge, US
Kevin Mills(Executive Officer, Director)inRonald Goldstein(Executive Officer)inDonald Corcoran(Executive Officer, Director)inMarkus Renschler(Director)in
BoardTimothy Romberger(Director)Barry Mills(Director)
Co-investorsDroia VenturesLightstone VenturesOUP (Osage University Partners)Shah Family OfficeAlly Bridge GroupJanus Henderson Investors+3 more
EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.
BiotechHealthtechMedical DevicesSan Mateo, US
Philip Macdonald(Executive Officer)Louis Baldino(Executive Officer, Director)Lilip Lau(Executive Officer)Josh DeFonzo(Executive Officer)in
BoardMichael Carusi(Director)inArda Minocherhomjee(Director)
Co-investorsAccelmed PartnersCanaan PartnersEvidity Health CapitalLightstone VenturesVCFA GroupAdvanced Technology Ventures+2 more
Milo is an AI assistant that helps parents manage daily family tasks through text message conversations, combining large language models with human oversight to handle logistical and organizational work.
AI & Machine LearningConsumerSan Francisco, US
Avni Patel Thompson(CEO)inNik Swain(Full Stack Engineer)Archa Jain(CTO)
Co-investorsBronze InvestmentsM13Y CombinatorAlteria CapitalAntlerBessemer Venture Partners+4 more
OnCusp Therapeutics develops oncology therapeutics for cancer treatment, including antibody-drug conjugates and small molecule compounds in clinical and preclinical stages.
BiotechMedical DevicesNew York, US
Dr. Bing Yuan(Co-Founder, Chief Executive Officer)Dr. Eric Slosberg(Co-Founder, Chief Development Officer)Dr. Andy Fu(Co-Founder, Chief Business Officer)Bing Yuan, Ph.D., MBA(Co-Founder, Chief Executive Officer)Eric Slosberg, Ph.D.(Co-Founder, Chief Development Officer)Andy Fu, PharmD, MBA(Co-Founder, Chief Business Officer)
Co-investorsOrbiMedCatalio Capital Management, LPF-Prime CapitalSofinnova VenturesInsight PartnersNVIDIA
StrideBio develops gene therapies based on its STRIVE AAV capsid platform, targeting people with life-threatening diseases.
BiotechHealthtechDurham, US
Aravind Asokan(Director)inMavis Abjandje-McKenna(Director)Richard Smith(Executive Officer)inPatrick Ritschel(Executive Officer, Director, Promoter)
Co-investorsPontifax Venture CapitalAbingworthHatteras Venture PartnersNorthpond Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Fund performance · per public LP disclosures · 4
as of Jun 2020| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| De Novo Ventures IIILPs: The Regents of the University of California | 2006 | — | -9.8% | 0.69x | 0.69x |
| De Novo Ventures III, L.PLPs: The Regents of the University of California | 2006 | — | -9.8% | 0.69x | 0.69x |
| De Novo Ventures IILPs: The Regents of the University of California | 2003 | — | -13.3% | 0.40x | 0.40x |
| De Novo Ventures II, L.PLPs: The Regents of the University of California | 2003 | — | -13.3% | 0.40x | 0.40x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- How many investments has De Novo Ventures made?
- De Novo Ventures has 9 tracked investments.
- What sectors does De Novo Ventures focus on?
- De Novo Ventures focuses on Biotech, Consumer, EdTech, Healthtech.
- Where is De Novo Ventures located?
- De Novo Ventures is headquartered in Boston, US.
Co-investors · 6
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
Venrock is a venture capital firm investing across technology and healthcare, backing companies in fintech, developer infrastructure, life sciences, therapeutics, semiconductors, and consumer products.
OrbiMed is a healthcare-focused investment firm providing tailored financing solutions and global resources to build world-class healthcare companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
RA Capital Management is a healthcare and planetary health investment firm that founds, funds, and scales companies using scientific diligence, multi-stage capital, and hands-on operational support.
Aisling Capital is an investment firm focused on companies developing and commercializing innovative healthcare products, services, and technologies.
Longwood Fund is a venture capital firm that creates and invests in novel healthcare companies developing new treatments for patients, drawing on its partners' company-building and operating experience.
Firms observed investing alongside De Novo Ventures, from public investor directories. Shared companies are the overlap with De Novo Ventures's recorded portfolio.
Similar investors
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Blume Ventures is a seed and pre-Series A investment firm headquartered in Mumbai that focuses on early-stage companies in India.
Fly Ventures is an early-stage venture firm that backs founders at the zero-to-one stage, with portfolio companies going on to raise substantial follow-on funding from top US and European VCs.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Kibo Ventures is a Spanish venture capital firm that backs startups, having served as an early and long-term institutional investor to companies across Spain and Europe.